Not yet taking people in BelgiumPhase 4
Testing extra-fine inhaled steroid particles in people with COPD
Tests whether extra-fine inhaled steroid particles affect small airways in adults with COPD.
Key facts
- Who runs it
- CHU Saint Pierre
- Where
- Brussels, BelgiumSee the site
- Trial code
- Registry title
- The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 60 people, planned
- Started
- 1 Dec 2025
- Planned end
- 30 Mar 2026
- Type of study
- Interventional
- Record updated
- 19 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic obstructive pulmonary disease (COPD). It studies how extra-fine inhaled corticosteroid particles affect the small airways.
- Age
- 18 years or older
- Sex
- All sexes can join.
Where in Belgium
- CHU Saint-PierreBrussels, BelgiumNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Testing extra-fine inhaled steroid particles in people with COPDGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 19 January 2026